Percutaneous coronary intervention: basic principles and guidelines
|
Percutaneous Coronary Intervention Guidelines Microchapters |
|
PCI Approaches: |
|---|
|
CAD Revascularization: |
|
Pre-procedural Considerations: |
|
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
|
Quality and Performance Considerations: |
|
Percutaneous coronary intervention: basic principles and guidelines On the Web |
|
American Roentgen Ray Society Images of Percutaneous coronary intervention: basic principles and guidelines |
|
FDA on Percutaneous coronary intervention: basic principles and guidelines |
|
CDC on Percutaneous coronary intervention: basic principles and guidelines |
|
Percutaneous coronary intervention: basic principles and guidelines in the news |
|
Blogs on Percutaneous coronary intervention: basic principles and guidelines |
|
Directions to Hospitals Treating Percutaneous Coronary Intervention |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Synonyms and keywords: PCI; balloon angioplasty; percutaneous transluminal angioplasty
Overview
Guideline Recommendations
CAD Revascularization
Heart Team Approach to Revascularization Decisions | Left Main Coronary Artery Disease | Non-Left Main Coronary Artery Disease | Revascularization to Improve Symptoms | Dual Antiplatelet Therapy Compliance and Stent Thrombosis | Hybrid Coronary Revascularization
Pre-procedural Considerations
Contrast-Induced Acute Kidney Injury | Anaphylactoid Reactions | Statin Treatment | Bleeding Risk | Role of Onsite Surgical Backup
Procedural Considerations
- Vascular Access
- PCI in Specific Clinical Situations:
- Asymptomatic Ischemia or CCS Class I or II Angina
- CCS Class III Angina
- Unstable Angina/Non–ST-Elevation Myocardial Infarction
- ST-Elevation Myocardial Infarction: General and Specific Considerations | Coronary Angiography Strategies in STEMI | Primary PCI of the Infarct Artery | Delayed or Elective PCI in patients with STEMI | Fibrinolytic-Ineligible Patients | Facilitated PCI | Rescue PCI | After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
- Cardiogenic Shock
- Prior Coronary Bypass Surgery
- Revascularization Before Non-cardiac Surgery
- Adjunctive Diagnostic Devices: Fractional Flow Reserve | Intravascular Ultrasound
- Adjunctive Therapeutic Devices: Coronary Atherectomy | Thrombectomy | Laser Angioplasty | Cutting Balloon Angioplasty | Embolic Protection Devices
- Percutaneous Hemodynamic Support Devices
- Antiplatelet therapy:
- Oral Antiplatelet Therapy
- Glycoprotein IIb/IIIa Receptor Antagonists
- Intravenous Antiplatelet therapy: STEMI | UA/NSTEMI | SIHD
- Anticoagulant Therapy: Parenteral Anticoagulants During PCI | Unfractionated Heparin | Enoxaparin | Bivalirudin and Argatroban | Fondaparinux | No-Reflow Pharmacological Therapies
- PCI in Specific Anatomic Situations: Chronic Total Occlusions | Saphenous Vein Grafts | Bifurcation Lesions | Aorto-Ostial Stenoses | Calcified Lesions
- PCI in Specific Patient Populations: Chronic Kidney Disease
- Peri-procedural Myocardial Infarction Assessment
- Vascular Closure Devices
Post-Procedural Considerations
- Post-procedural Antiplatelet Therapy
- Proton Pump Inhibitors and Antiplatelet Therapy
- Clopidogrel Genetic Testing
- Platelet Function Testing
- Restenosis
- Exercise Testing
- Cardiac Rehabilitation
Quality and Performance Considerations
Quality and Performance | Certification and Maintenance of Certification | Operator and Institutional Competency and Volume